Novel N-(4-Piperidinyl)benzamide Antimalarials with Mammalian Protein Farnesyltransferase Inhibitory Activity

A Ryckebusch 1 Pauline Gilleron 1 R Millet 1 R Houssin 1 A Lemoine 1 N Pommery 1 Philippe Grellier 2 C Sergheraert 3 J-P Henichart 1
1 ICPAL - Institut de Chimie Pharmaceutique Albert Lespagnol
2 MCAM - Molécules de Communication et Adaptation des Micro-organismes (MCAM)
3 SSFB - Synthèse, structure et fonction des biomolécules
Abstract : Protein farnesyltransferase of Plasmodium falciparum is a potential target in the treatment of malaria for which increased drug resistance is observed. The design, synthesis and evaluation of a series of N-(4-piperidinyl)benzamides is reported. The most potent compounds showed in vitro activity against the parasite at submicromolar concentrations.
Keywords : inhibitor 1324 farnesyltransferase malaria Plasmodium falciparum N-(4-piperidinyl)benzamide derivative
Document type :
Journal articles
Complete list of metadatas

Cited literature [28 references]  Display  Hide  Download
https://hal-mnhn.archives-ouvertes.fr/mnhn-02070112
Contributor : Philippe Grellier <>
Submitted on : Saturday, March 16, 2019 - 5:58:21 PM
Last modification on : Thursday, March 21, 2019 - 1:00:53 AM
Long-term archiving on : Monday, June 17, 2019 - 3:46:24 PM

File

53_1324.pdf
Publisher files allowed on an open archive

Identifiers

Collections

MNHN

Citation

A Ryckebusch, Pauline Gilleron, R Millet, R Houssin, A Lemoine, et al.. Novel N-(4-Piperidinyl)benzamide Antimalarials with Mammalian Protein Farnesyltransferase Inhibitory Activity. Chemical and Pharmaceutical Bulletin, Pharmaceutical Society of Japan, 2005, 53 (10), pp.1324-1326. ⟨10.1248/cpb.53.1324⟩. ⟨mnhn-02070112⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

14

Files downloads

22

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD